These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15076148)

  • 1. Renin-angiotensin system blockade: to what extent?
    Ménard J; Azizi M
    J Hypertens; 2004 Mar; 22(3):459-62. PubMed ID: 15076148
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract]   [Full Text] [Related]  

  • 3. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A; Redón J
    Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
    [No Abstract]   [Full Text] [Related]  

  • 4. Obesity hypertension: the rationale for renin-angiotensin system blockade.
    Chan NN; Tong PC; Kong AP; Chan JC
    Hong Kong Med J; 2005 Jun; 11(3):217-20. PubMed ID: 15951590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct renin inhibitors in hypertension - approaching the moment of truth.
    Hedner T; Narkiewicz K; Oparil S; Kjeldsen SE
    Blood Press; 2012 Oct; 21(5):267-8. PubMed ID: 23013445
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertensive treatment in light of the latest discoveries in the renin-angiotensin system].
    Traub Y
    Harefuah; 1996 Feb; 130(3):195-9. PubMed ID: 8682399
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists.
    Nicholls C; Sani M
    Nurs Older People; 2004; 16(5):31-2. PubMed ID: 15303516
    [No Abstract]   [Full Text] [Related]  

  • 9. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension.
    Laragh J
    Am J Hypertens; 2001 Jun; 14(6 Pt 1):491-503. PubMed ID: 11411727
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of the renin-angiotensin system in hypertension in the elderly.
    Nagano M; Higaki J; Mikami H; Ogihara T
    Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete renin-angiotensin-aldosterone system (RAAS) blockade in high-risk patients: recent insights from renin blockade studies.
    Rajagopalan S; Bakris GL; Abraham WT; Pitt B; Brook RD
    Hypertension; 2013 Sep; 62(3):444-9. PubMed ID: 23876474
    [No Abstract]   [Full Text] [Related]  

  • 14. Renin inhibition: the holy grail of renin-angiotensin system blockade?
    McInnes GT
    J Hum Hypertens; 2007 Oct; 21(10):766-9. PubMed ID: 17541389
    [No Abstract]   [Full Text] [Related]  

  • 15. Aliskiren: beyond blood pressure reduction.
    Riccioni G; Vitulano N; Zanasi A; Bellocci F; d'Orazio N
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1265-74. PubMed ID: 20812878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin angiotensin system inhibition in the older person: a review.
    Mohamed MA; Weir MR
    Clin Geriatr Med; 2009 May; 25(2):245-57. PubMed ID: 19555871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions.
    Willenheimer R; Dahlöf B; Rydberg E; Erhardt L
    Eur Heart J; 1999 Jul; 20(14):997-1008. PubMed ID: 10381851
    [No Abstract]   [Full Text] [Related]  

  • 19. Renin inhibition in hypertension.
    Gradman AH; Kad R
    J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct renin inhibition: another weapon to modulate the renin-angiotensin system in postinfarction remodeling?
    Perlini S; Salinaro F; Fonte ML
    Hypertension; 2008 Dec; 52(6):1019-21. PubMed ID: 18955659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.